Vutiglabridin | Interleukin Related interleukin-related.com

Product Name :
Vutiglabridin

Search keywords :
Vutiglabridin

drugId :
null

Target Vo:
Undisclosed

Target Vo Short Name :
Undisclosed

Moa_Name:
Triglyceride modulators

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Glaceum

Active Company_Name :
Glaceum

Active Indication_Name:
Parkinson Disease

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Phase 2 Clinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
SOX2 Rabbit mAb web
Biotin-conjugated Anti-Mouse IgG H&L web
NF-κB p105/p50 Antibody: NF-κB p105/p50 Antibody is a non-conjugated and Mouse origined monoclonal antibody about 50 kDa, targeting to NF-κB p105/p50. It can be used for WB,ICC,IHC-P assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts